Biomarker Analysis and Updated Results From the Phase Iii Propel Trial of Abiraterone (abi) and Olaparib (ola) Vs Abi and Placebo (pbo) as First-Line (1l) Therapy for Patients (pts) With Metastatic Castration-Resistant Prostate Cancer (mcrpc)
| dc.contributor.author | Saad, F. | |
| dc.contributor.author | Armstrong, A. J. | |
| dc.contributor.author | Thiery-Vuillemin, A. | |
| dc.contributor.author | Oya, M. | |
| dc.contributor.author | Shore, N. D. | |
| dc.contributor.author | Procopio, G. | |
| dc.contributor.author | Arslan, C. | |
| dc.date.accessioned | 2023-06-16T14:56:45Z | |
| dc.date.available | 2023-06-16T14:56:45Z | |
| dc.date.issued | 2022 | |
| dc.description | Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- SEP 09-13, 2022 -- ELECTR NETWORK | en_US |
| dc.description.abstract | [Abstract Not Available] | en_US |
| dc.description.sponsorship | European Soc Med Oncol | en_US |
| dc.description.sponsorship | AstraZeneca; Merck Sharp Dohme LLC | en_US |
| dc.description.sponsorship | AstraZeneca and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. | en_US |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/3235 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annals of Oncology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Biomarker Analysis and Updated Results From the Phase Iii Propel Trial of Abiraterone (abi) and Olaparib (ola) Vs Abi and Placebo (pbo) as First-Line (1l) Therapy for Patients (pts) With Metastatic Castration-Resistant Prostate Cancer (mcrpc) | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::conference output | |
| gdc.description.department | İzmir Ekonomi Üniversitesi | en_US |
| gdc.description.departmenttemp | [Saad, F.] Univ Montreal, Dept Urol, Ctr Hosp, CRCHUM, Montreal, PQ, Canada; [Armstrong, A. J.] Duke Canc Inst Ctr, Dept Med, Durham, NC USA; [Thiery-Vuillemin, A.] CHRU Besancon Hop J Minjoz, Med Oncol Dept, Besancon, France; [Oya, M.] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Shore, N. D.] Carolina Urol Res Ctr, Surg & Oncol, Myrtle Beach, SC USA; [Procopio, G.] Ist Nazl Cura Tumori Milano, Dept Med Oncol, Milan, Italy; [Arslan, C.] Izmir Econ Univ, Med Pk Hosp, Dept Med Oncol, Izmir, Turkey; [Mehra, N.] Radboud Univ Med Centrum, Med Oncol Dept, Nijmegen, Netherlands; [Parnis, F.] Ashford Canc Ctr Res, Dept Med Oncol, Kurralta Park, SA, Australia; [Brown, E.] Southampton Univ Hosp, Med Oncol Dept, Southampton, England; [Schlurmann, F. Constans] Ctr Hosp Cornouaille, Dept Med Oncol, Quimper, France; [Joung, J. Y.] Natl Canc Ctr, Ctr Urol Canc, Goyang Si, South Korea; [Sugimoto, M.] Kagawa Univ Hosp, Dept Urol, Kagawa, Japan; [Sartor, O.] Tulane Canc Ctr, Dept Hematol Oncol, New Orleans, LA USA; [Liu, Y-Z.] Astrazeneca, Precis Med, Oncol R&D, Cambridge, England; [Poehlein, C. H.] Clin Res Merck & Co Inc, Rahway, NJ USA; [Desai, C.; Del Rosario, P. M. D.] AstraZeneca, Global Med Dev, Oncol R&D, Cambridge, England; [Clarke, N.] Christie & Salford Royal NHS Foun dation Trusts, Dept Urol, Manchester, England | en_US |
| gdc.description.endpage | S1160 | en_US |
| gdc.description.issue | 7 | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | S1160 | en_US |
| gdc.description.volume | 33 | en_US |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.wos | WOS:000866211601614 | |
| gdc.index.type | WoS | |
| gdc.virtual.author | Arslan, Çağatay | |
| gdc.wos.citedcount | 10 | |
| relation.isAuthorOfPublication | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isAuthorOfPublication.latestForDiscovery | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isOrgUnitOfPublication | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd |
Files
Original bundle
1 - 1 of 1